Health Research, Inc.;Tracon Pharmaceuticals, Inc.
发明人:
申请号：
EP17194562.9
公开号：
EP3281637A1
申请日:
2010.08.16
申请国别(地区):
EP
年份:
2018
代理人:
摘要：
The present application relates to compositions of chimeric anti-endoglin antibodies and anti-VEGF agents. Another aspect relates to the use of chimeric anti-endoglin antibodies and Bevacizumab. Another aspect relates to the use of the compositions to inhibit VEGF induced sprouting. Another aspect relates to the use of the compositions to inhibit angiogenesis.
